Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J01M QUINOLONE ANTIBACTERIALS
J01MA Fluoroquinolones
J01MA16 Gatifloxacin
D00589 Gatifloxacin (USAN) <JP/US>
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01A ANTIINFECTIVES
S01AE Fluoroquinolones
S01AE06 Gatifloxacin
D00589 Gatifloxacin (USAN) <JP/US>
USP drug classification [BR:br08302]
Ophthalmic Agents
Ophthalmic Anti-Infectives
Antibacterials, Ophthalmic
Gatifloxacin
D00589 Gatifloxacin (USAN)
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
13 Agents affecting sensory organs
131 Ophthalmic agents
1319 Others
D00589 Gatifloxacin (USAN); Gatifloxacin hydrate (JP18)
Drug groups [BR:br08330]
Antibacterial
DG01550 Quinolone
DG01549 Fluoroquinolone
DG00628 Gatifloxacin
D00589 Gatifloxacin
Drug classes [BR:br08332]
Antibacterial
DG01549 Fluoroquinolone
D00589 Gatifloxacin
Antimicrobials [BR:br08307]
Antibacterials
Nucleic acid synthesis inhibitor
Fluoroquinolone
D00589 Gatifloxacin (USAN) <JP/US>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00589 Gatifloxacin hydrate
D00589 Gatifloxacin ophthalmic solution
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D00589
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D00589
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D00589
Drug groups [BR:br08330]
Antibacterial
DG01550 Quinolone
DG01549 Fluoroquinolone
DG00628 Gatifloxacin
Antimicrobials abbreviations [BR:br08327]
Antibacterials
Nucleic acid synthesis inhibitor
Fluoroquinolone
DG00628 Gatifloxacin